This week, Russia made global headlines with the announcement of a groundbreaking mRNA cancer vaccine set to be distributed free to its citizens in 2025. Designed to inhibit tumor growth and spread, pre-clinical trials have shown promising results. Researchers are also leveraging AI to personalize these vaccines, potentially reducing production time to less than an hour—a significant leap forward in cancer treatment. The world is waiting on more detailed information, but here’s what we know so far.
Read More: Explainer: Russia launches new cancer vaccine; how does it work?
Disclaimer: The entire content of this website is based on research conducted by the Templeton Wellness Foundation (TWF), unless otherwise noted. The information is presented for educational purposes only and is not intended to diagnose or prescribe any medical or psychological condition, nor to prevent, treat, mitigate or cure such conditions. The information contained herein is not intended to replace a one-on-one relationship with a doctor or qualified healthcare professional and is not intended as medical advice. It is intended as a sharing of knowledge and information based on research and experience. TWF encourages you to make your own health care decisions based on your judgment and research in partnership with a qualified healthcare professional.
